CLINICAL ROLE -
USP : New Regulations to Protect Health Care Workers from Hazardous Drugs
Pharmacists need to be aware of the ways in which draft regulations developed by the United States Pharmacopeia are likely to affect the handling of potentially hazardous drugs.
Biosimilars: The Perfect Fit for Specialty!
The first biosimilar product in the United States has been approved, and the time is now for specialty pharmacists to become familiar with the use and regulation of these drugs.
Price vs Patient Access: Specialty's Unsettling Conundrum
As specialty medication costs rise, stakeholders seek to find a balance between cost containment and patient access.
The FDA's Outsourcing Facility Designation: What It Means and Why It Matters
A pharmacy that seeks to register as an outsourcing facility will likely need to make investments in infrastructure and training in order to comply with the Drug Quality and Security Act.
The Unique Competencies of Oncology Pharmacy
Specialty pharmacists are instrumental in addressing the particular needs of patients undergoing highly specialized cancer treatments.
Prevent Potential Liability to State and Federal Agencies for "Excluded Providers"
Health care and pharmacy practices must regularly verify that their employees are not excluded from participation in Medicare, Medicaid, or other federal health programs.
mHealth Emerges as the New Essential Strategy for Specialty Pharmacies
Health care providers can utilize mobile health technology to provide patients with targeted adherence reminders and disease management guidance.
The Real Scoop on Data Warehouses
The implementation of a data warehouse, a relational database for query and analysis, can help a specialty pharmacy utilize its data to the fullest.
Brave New World
New Approach May Prevent Strictures in Crohn's Disease
Novel HIV Drug Candidate Highly Effective
Experimental HIV Drug Shows Promising Results in Study
HIV Postoperative Mortality Reduced by ART
What to Remember About Refill Reminders
Specialty pharmacies must consider how their marketing programs intersect with Health Insurance Portability and Accountability Act marketing rules.
Crohn's Disease Patients More Likely to Develop Neurological Issues
Intestinal Repair in Crohn's Disease Influenced by Gut Bacteria
Triumeq by ViiV Healthcare
The FDA approved Triumeq (abacavir, dolutegravir, and lamivudine) tablets for the treatment of HIV-1 infection in patients without the HLA-B*5701 allele.
US Bioservices Customizes Patient Care
US Bioservices offers nationwide specialty pharmacy and nursing services tailored to meet the needs of patients, physicians, payers, and manufacturers.
Specialty Pharmacists Play a Vital Part in the Treatment of Hepatitis C
Pharmacists provide medication expertise that is essential to both the patient and the health care team in the treatment of hepatitis C.
Track-and-Trace Law Puts Supply Chain Under Scrutiny
In an effort to prevent the transfer of stolen or counterfeit drugs, a new law will require pharmacies to supply more data about pharmaceutical shipments moving through the supply chain.
